ArticleAdvanced healthcare materials2026
Hierarchically Engineered Magnetic-Enzymatic Microrobots with Stimuli-Induced Disassembly for Controlled Navigation and Mucosal Penetration in 3D Lung Fibrosis Models.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Magnetically Guided Macrophage Immunobots Coordinate Iron-Metabolic Cascades and Immunogenic Ferroptosis for Tumor Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Micro/nanorobots offer a promising approach for active therapeutic delivery to hard-to-access regions of the body. For pulmonary fibrosis, however, targeted drug delivery remains difficult because the disease has spatially heterogeneous fibrotic lesions and mucus accumulation. Importantly, achieving lesion targeting and mucus penetration remains challenging due to the trade-off between long-distance navigation and the ability to traverse dense biological barriers. Here, we present a hierarchically structured microrobot that integrates magnetically driven microrollers with self-propelled enzymatic nanomotors for sequential drug delivery via a thioketal linker responsive to reactive oxygen species (ROS). The hierarchical microrobots exhibit programmable navigation on inclined, mucus-coated surfaces under airflow and undergo disassembly in oxidative fibrotic environments. Following deployment, the released enzymatic nanomotors actively penetrate mucus barriers and deliver anti-fibrotic drugs. In a three-dimensional (3D) in vitro fibrosis model incorporating a mucus-epithelial barrier, drug-loaded enzymatic nanomotors achieve superior penetration and significantly greater anti-fibrotic efficacy than passive nanoparticles. Overall, this work establishes a hierarchical microrobotic platform that enables both targeted transport and active mucus penetration for localized therapeutic delivery in complex biological environments and provides a general strategy for integrating targeting and tissue penetration within a single platform.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.